Drug
ZL 2306 Niraparib
ZL 2306 Niraparib: highest development phase Phase 2, developed by Zai Lab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZL-2306(Niraparib） NCT04392102 | Phase 2 | Ovarian Cancer |
Latest
No recent events.
Follow ZL 2306 Niraparib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.